Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • S256: HLA-E/NKG2A CHECKPOINT D...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY

S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY

Bibliographic Details
Main Authors: Jessica Encinas, Almudena García-Ortiz, Elena Maroto-Martín, Eva Castellano, Raquel Oliva, Rafael Alonso Fernández, Maria Teresa Cedena Romero, Alejandra Leivas, Beatriz Martín-Antonio, Guillermo Suñe, Dean A. Lee, Daniel J. Powell, Jr., Paula Río, Joaquín Martinez-Lopez, Antonio Valeri
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000967936.16745.e9
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000967936.16745.e9

Similar Items

  • Overcoming tumor resistance mechanisms in CAR-NK cell therapy
    by: Antonio Valeri, et al.
    Published: (2022-08-01)
  • Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
    by: Jack G. Fisher, et al.
    Published: (2022-11-01)
  • Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy
    by: Yan Li, et al.
    Published: (2024-10-01)
  • The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
    by: Meike Kaulfuss, et al.
    Published: (2023-06-01)
  • NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
    by: Alejandra Leivas, et al.
    Published: (2021-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs